Lebanon: A recent study analyzing data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) has ...

Here are three of the biggest mistakes that doctors say people make while taking Ozempic and similar medications. 🩺 SIGN UP ...

The following text highlights some of these precautions. Boxed warning: Risk of thyroid cancer Semaglutide (the active ingredient in Ozempic and Wegovy) has a boxed warning for a possible risk of ...

Semaglutide and newer GLP-1 drugs help people lose substantially ... published last month in the journal Food Quality and Preference. Does Ozempic Really Cause Thyroid Cancer? What the Science ...

Non-surgical weight loss treatments are becoming more accessible, effective, and more in tune with your body's natural ...

The EMA, as well as the FDA in the US, have approved labelling for Wegovy that mentions that semaglutide has been ... people with a family history of thyroid cancer. In a statement, the EMA ...

Ozempic and similar semaglutide-based medications have been ... Rarely, serious side effects such as pancreatitis and thyroid cancer can occur. "It's too early to know whether using GLP-1s to ...

Tirzepatide (Mounjaro) launched in India in March 2025, promising new hope for diabetes and obesity treatment. An expert ...

2 It is important to note that semaglutide injection 2.4 mg contains a Boxed Warning for possible thyroid tumors, including cancer and should not be used in those with a personal or family history ...

In animal studies, semaglutide (the active drug in Ozempic and Wegovy) has been shown to cause thyroid tumors and thyroid cancer. Doctors don’t know if it can cause thyroid cancers in people.

GLP-1 receptor agonists like semaglutide were originally developed ... studies have raised concerns about a possible risk of thyroid cancer, although this has not yet been observed in humans.